Kappadione

Kappadione is a Vitamin K derivative. It was manufactured by Eli Lilly and Company.[1] Chemically, it is menadiol sodium diphosphate. It was previously approved by FDA prior to 1982 and marketed by Lilly Marketing. This has been discontinued and is not available in North America.

Kappadione
Clinical data
Routes of
administration
Injection
ATC code
  • none
Legal status
Legal status
  • US: Rx only, discontinued (was FDA Approved)
  • In general: ℞ (Prescription only)
Identifiers
IUPAC name
  • Tetrasodium (2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.004.558
Chemical and physical data
FormulaC11H8Na4O8P2
Molar mass422.084 g·mol−1
3D model (JSmol)
SMILES
  • CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]
InChI
  • InChI=1S/C11H12O8P2.4Na/c1-7-6-10(18-20(12,13)14)8-4-2-3-5-9(8)11(7)19-21(15,16)17;;;;/h2-6H,1H3,(H2,12,13,14)(H2,15,16,17);;;;/q;4*+1/p-4 N
  • Key:GZBACHSOZNEZOG-UHFFFAOYSA-J N
 NY (what is this?)  (verify)

References

  1. "Kappadione overview, medicine.org". Archived from the original on 2016-03-03. Retrieved 2008-04-14.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.